Infertility Testing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Female Infertility Testing and Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormo
Description
The infertility testing market size was valued at US$ 494.7 million in 2024 and is expected to reach US$ 871.3 million by 2031; it is estimated to record a CAGR of 8.6% from 2025 to 2031.
The infertility testing market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2024, followed by Europe and the Asia Pacific, respectively.
The female infertility testing segment encompasses a variety of diagnostic procedures aimed at identifying underlying causes of infertility in women. Key tests include hormonal profiling, ovarian reserve assessment, hysterosalpingography (HSG), pelvic ultrasounds, and laparoscopy. Hormonal profiling evaluates levels of hormones such as FSH, LH, AMH, and prolactin, which play critical roles in ovulation and reproductive health. Ovarian reserve testing helps determine the quantity and quality of a woman’s eggs, aiding in predicting fertility potential. HSG and hysterosonography are employed to examine the uterine cavity and fallopian tube patency, detecting structural abnormalities or blockages. Advanced imaging and minimally invasive procedures like laparoscopy are used for diagnosing conditions such as endometriosis or pelvic adhesions, which may impair fertility. Rising awareness regarding reproductive health, increasing maternal age, and the prevalence of gynecological disorders are driving demand for female infertility testing. Furthermore, innovations in diagnostic technologies, including genetic testing and non-invasive imaging, are enhancing the accuracy and efficiency of assessments, positioning this segment as a critical component of the overall infertility testing market.
The male infertility testing segment focuses on evaluating factors that affect male reproductive health, contributing to nearly 40–50% of infertility cases globally. Core diagnostic procedures include semen analysis, hormonal testing, genetic testing, and imaging studies. Semen analysis is the most common method, assessing sperm count, motility, morphology, and overall seminal quality. Hormonal testing measures levels of testosterone, FSH, LH, and prolactin, providing insight into endocrine causes of infertility. Genetic testing identifies chromosomal abnormalities or Y-chromosome microdeletions that may impact sperm production or function. Imaging techniques such as scrotal ultrasound or Doppler studies detect structural issues like varicocele or testicular abnormalities.
Infertility testing market future trend: Digital health innovations — ranging from mobile apps and connected at‑home diagnostic tools to full telemedicine platforms — are breaking down traditional barriers to care and enabling earlier, more personalized engagement with fertility testing than ever before. Integration of telehealth into fertility diagnostics offers convenience, reduced travel burden, and continuous support that better fits modern lifestyles. For individuals and couples navigating sensitive reproductive health concerns, the ability to connect virtually with specialists and receive timely interpretations of fertility test results has proven essential for engagement and care continuity.
The proliferation of direct‑to‑consumer fertility testing models blends digital interfaces with clinical diagnostics. Companies such as Modern Fertility and Natalist have pioneered services where customers order hormone test kits online, collect samples at home, receive results electronically, and follow up with expert telehealth consultations — all within a digital ecosystem. Such models improve accessibility and foster ongoing user engagement through personalized digital portals. Digital tools such as fertility tracking apps and wearable monitors are now frequently integrated into diagnostic pathways. These platforms collect real‑time physiological data, offer cycle predictions, and enable remote monitoring by healthcare providers — helping to capture critical fertility indicators without repeated in‑person clinic visits. Patients report high adoption rates and helpfulness of these tools, reflecting their role in empowering users to understand better and manage reproductive health. In clinical settings, telemedicine is transforming patient‑provider interaction by facilitating virtual consultations, remote follow‑ups, and digital transmission of test results, which enhance continuity of care and patient satisfaction. This digital transformation is impactful for those in remote areas or with mobility constraints, improving the efficiency and patient experience of fertility diagnostics.
Quest Diagnostics Inc; Church & Dwight Co Inc; Swiss Precision Diagnostics GmbH; bioMérieux SA; QuidelOrtho Corp; Abbott Laboratories; Thermo Fisher Scientific Inc; Prestige Consumer Healthcare Inc.; LetsGetChecked; and Mira companies are among the key players profiled during this market study. Several other essential market players were also studied and analyzed to get a holistic view of the global infertility testing market and its ecosystem.
The overall infertility testing market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the infertility testing market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the infertility testing market.
Reasons to Buy
Saves and reduces time required for identifying the market growth, size, leading players, and segments in the global Infertility Testing market.
Highlights key business priorities to assist companies in realigning their business strategies
Emphasizes key findings and recommendations that uncover emerging industry trends in the global Infertility Testing market, enabling stakeholders across the value chain to craft effective long-term strategies
Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
Scrutinizes in-depth global Infertility Testing market trends, along with factors driving the market, as well as those hindering it
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
The infertility testing market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2024, followed by Europe and the Asia Pacific, respectively.
The female infertility testing segment encompasses a variety of diagnostic procedures aimed at identifying underlying causes of infertility in women. Key tests include hormonal profiling, ovarian reserve assessment, hysterosalpingography (HSG), pelvic ultrasounds, and laparoscopy. Hormonal profiling evaluates levels of hormones such as FSH, LH, AMH, and prolactin, which play critical roles in ovulation and reproductive health. Ovarian reserve testing helps determine the quantity and quality of a woman’s eggs, aiding in predicting fertility potential. HSG and hysterosonography are employed to examine the uterine cavity and fallopian tube patency, detecting structural abnormalities or blockages. Advanced imaging and minimally invasive procedures like laparoscopy are used for diagnosing conditions such as endometriosis or pelvic adhesions, which may impair fertility. Rising awareness regarding reproductive health, increasing maternal age, and the prevalence of gynecological disorders are driving demand for female infertility testing. Furthermore, innovations in diagnostic technologies, including genetic testing and non-invasive imaging, are enhancing the accuracy and efficiency of assessments, positioning this segment as a critical component of the overall infertility testing market.
The male infertility testing segment focuses on evaluating factors that affect male reproductive health, contributing to nearly 40–50% of infertility cases globally. Core diagnostic procedures include semen analysis, hormonal testing, genetic testing, and imaging studies. Semen analysis is the most common method, assessing sperm count, motility, morphology, and overall seminal quality. Hormonal testing measures levels of testosterone, FSH, LH, and prolactin, providing insight into endocrine causes of infertility. Genetic testing identifies chromosomal abnormalities or Y-chromosome microdeletions that may impact sperm production or function. Imaging techniques such as scrotal ultrasound or Doppler studies detect structural issues like varicocele or testicular abnormalities.
Infertility testing market future trend: Digital health innovations — ranging from mobile apps and connected at‑home diagnostic tools to full telemedicine platforms — are breaking down traditional barriers to care and enabling earlier, more personalized engagement with fertility testing than ever before. Integration of telehealth into fertility diagnostics offers convenience, reduced travel burden, and continuous support that better fits modern lifestyles. For individuals and couples navigating sensitive reproductive health concerns, the ability to connect virtually with specialists and receive timely interpretations of fertility test results has proven essential for engagement and care continuity.
The proliferation of direct‑to‑consumer fertility testing models blends digital interfaces with clinical diagnostics. Companies such as Modern Fertility and Natalist have pioneered services where customers order hormone test kits online, collect samples at home, receive results electronically, and follow up with expert telehealth consultations — all within a digital ecosystem. Such models improve accessibility and foster ongoing user engagement through personalized digital portals. Digital tools such as fertility tracking apps and wearable monitors are now frequently integrated into diagnostic pathways. These platforms collect real‑time physiological data, offer cycle predictions, and enable remote monitoring by healthcare providers — helping to capture critical fertility indicators without repeated in‑person clinic visits. Patients report high adoption rates and helpfulness of these tools, reflecting their role in empowering users to understand better and manage reproductive health. In clinical settings, telemedicine is transforming patient‑provider interaction by facilitating virtual consultations, remote follow‑ups, and digital transmission of test results, which enhance continuity of care and patient satisfaction. This digital transformation is impactful for those in remote areas or with mobility constraints, improving the efficiency and patient experience of fertility diagnostics.
Quest Diagnostics Inc; Church & Dwight Co Inc; Swiss Precision Diagnostics GmbH; bioMérieux SA; QuidelOrtho Corp; Abbott Laboratories; Thermo Fisher Scientific Inc; Prestige Consumer Healthcare Inc.; LetsGetChecked; and Mira companies are among the key players profiled during this market study. Several other essential market players were also studied and analyzed to get a holistic view of the global infertility testing market and its ecosystem.
The overall infertility testing market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the infertility testing market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the infertility testing market.
Reasons to Buy
Saves and reduces time required for identifying the market growth, size, leading players, and segments in the global Infertility Testing market.
Highlights key business priorities to assist companies in realigning their business strategies
Emphasizes key findings and recommendations that uncover emerging industry trends in the global Infertility Testing market, enabling stakeholders across the value chain to craft effective long-term strategies
Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
Scrutinizes in-depth global Infertility Testing market trends, along with factors driving the market, as well as those hindering it
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table of Contents
289 Pages
- 1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
- 2. Infertility Testing Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.4 Porter`s Five Force Analysis
- 2.5 PEST Analysis
- 2.6 Impact of Artificial Intelligence (AI)
- 2.7 Product or Technology Roadmap
- 2.8 Sustainability and ESG Trends
- 2.9 Regulatory Framework
- 3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Concentration
- 4. Infertility Testing Market – Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Global Incidence of Infertility
- 4.1.2 Surging Awareness & Demand for Fertility Health
- 4.1.3 Rising Adoption of Assisted Reproductive Technologies
- 4.2 Market Restraints
- 4.2.1 High Cost & Limited Insurance Coverage
- 4.2.2 Lesser Precision of Ovulation Prediction Kits
- 4.2.3 Challenges in Ovulation Detection Using Urine Tests in PCOS/PCOD Cases
- 4.3 Market Opportunities
- 4.3.1 Rising Demand for Preventive Fertility Screening
- 4.3.2 Public–Private Healthcare Collaborations
- 4.3.3 Rise of Home?Based and At?Home Testing Solutions
- 4.4 Future Trends
- 4.4.1 Expansion of Digital & Telehealth?Enabled Fertility Services
- 4.4.2 Advanced Genetic and Molecular Diagnostics
- 4.4.3 AI?Driven Predictive and Personalized Testing
- 4.5 Impact of Drivers and Restraints
- 5. Infertility Testing Market – Global Market Analysis
- 5.1 Infertility Testing Market Revenue (US$ Million), 2021–2031
- 5.2 Infertility Testing Market Forecast and Analysis
- 6. Infertility Testing Market Revenue Analysis –Type
- 6.1 Infertility Testing Market Forecasts and Analysis by Type
- 6.1.1 Female Infertility Testing
- 6.1.1.1 Overview
- 6.1.1.2 Female Infertility Testing: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 6.1.2 Male Infertility Testing
- 6.1.2.1 Overview
- 6.1.2.2 Male Infertility Testing: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 7. Infertility Testing Market Revenue Analysis –Test Kits
- 7.1 Infertility Testing Market Forecasts and Analysis by Test Kits
- 7.1.1 Human Follicular Stimulating Hormone (FSH) Test Kits
- 7.1.1.1 Overview
- 7.1.1.2 Human Follicular Stimulating Hormone (FSH) Test Kits: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 7.1.2 Luteinizing Hormone (LH) Test Kits
- 7.1.2.1 Overview
- 7.1.2.2 Luteinizing Hormone (LH) Test Kits: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 7.1.3 Human Chorionic Gonadotropin (HCG) Hormone Test Kits
- 7.1.3.1 Overview
- 7.1.3.2 Human Chorionic Gonadotropin (HCG) Hormone Test Kits: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 7.1.4 Others
- 7.1.4.1 Overview
- 7.1.4.2 Others: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 8. Infertility Testing Market Revenue Analysis –Sample
- 8.1 Infertility Testing Market Forecasts and Analysis by Sample
- 8.1.1 Blood
- 8.1.1.1 Overview
- 8.1.1.2 Blood: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 8.1.2 Urine
- 8.1.2.1 Overview
- 8.1.2.2 Urine: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 8.1.3 Others
- 8.1.3.1 Overview
- 8.1.3.2 Others: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 9. Infertility Testing Market Revenue Analysis –End User
- 9.1 Infertility Testing Market Forecasts and Analysis by End User
- 9.1.1 Homcare
- 9.1.1.1 Overview
- 9.1.1.2 Homcare: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 9.1.2 Hospital and Clinics
- 9.1.2.1 Overview
- 9.1.2.2 Hospital and Clinics: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 9.1.3 Fertility Centers
- 9.1.3.1 Overview
- 9.1.3.2 Fertility Centers: Infertility Testing Market –Revenue, 2021–2031 (US$ Million)
- 10. Infertility Testing Market – Geographical Analysis
- 10.1 North America
- 10.1.1 North America Infertility Testing Market Overview
- 10.1.2 North America: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.1.3 North America: Infertility Testing Market– By Segmentation
- 10.1.3.1 Type
- 10.1.3.2 Test Kits
- 10.1.3.3 Sample
- 10.1.3.4 End User
- 10.1.4 North America: Infertility Testing Market Breakdown by Countries
- 10.1.4.1 United States Market
- 10.1.4.1.1 United States: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.1.4.1.2 United States: Infertility Testing Market– By Segmentation
- 10.1.4.1.2.1 Type
- 10.1.4.1.2.2 Test Kits
- 10.1.4.1.2.3 Sample
- 10.1.4.1.2.4 End User
- 10.1.4.2 Canada Market
- 10.1.4.2.1 Canada: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.1.4.2.2 Canada: Infertility Testing Market– By Segmentation
- 10.1.4.2.2.1 Type
- 10.1.4.2.2.2 Test Kits
- 10.1.4.2.2.3 Sample
- 10.1.4.2.2.4 End User
- 10.1.4.3 Mexico Market
- 10.1.4.3.1 Mexico: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.1.4.3.2 Mexico: Infertility Testing Market– By Segmentation
- 10.1.4.3.2.1 Type
- 10.1.4.3.2.2 Test Kits
- 10.1.4.3.2.3 Sample
- 10.1.4.3.2.4 End User
- 10.2 Europe
- 10.2.1 Europe Infertility Testing Market Overview
- 10.2.2 Europe: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.3 Europe: Infertility Testing Market– By Segmentation
- 10.2.3.1 Type
- 10.2.3.2 Test Kits
- 10.2.3.3 Sample
- 10.2.3.4 End User
- 10.2.4 Europe: Infertility Testing Market Breakdown by Countries
- 10.2.4.1 United Kingdom Market
- 10.2.4.1.1 United Kingdom: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.1.2 United Kingdom: Infertility Testing Market– By Segmentation
- 10.2.4.1.2.1 Type
- 10.2.4.1.2.2 Test Kits
- 10.2.4.1.2.3 Sample
- 10.2.4.1.2.4 End User
- 10.2.4.2 Germany Market
- 10.2.4.2.1 Germany: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.2.2 Germany: Infertility Testing Market– By Segmentation
- 10.2.4.2.2.1 Type
- 10.2.4.2.2.2 Test Kits
- 10.2.4.2.2.3 Sample
- 10.2.4.2.2.4 End User
- 10.2.4.3 Italy Market
- 10.2.4.3.1 Italy: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.3.2 Italy: Infertility Testing Market– By Segmentation
- 10.2.4.3.2.1 Type
- 10.2.4.3.2.2 Test Kits
- 10.2.4.3.2.3 Sample
- 10.2.4.3.2.4 End User
- 10.2.4.4 France Market
- 10.2.4.4.1 France: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.4.2 France: Infertility Testing Market– By Segmentation
- 10.2.4.4.2.1 Type
- 10.2.4.4.2.2 Test Kits
- 10.2.4.4.2.3 Sample
- 10.2.4.4.2.4 End User
- 10.2.4.5 Spain Market
- 10.2.4.5.1 Spain: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.5.2 Spain: Infertility Testing Market– By Segmentation
- 10.2.4.5.2.1 Type
- 10.2.4.5.2.2 Test Kits
- 10.2.4.5.2.3 Sample
- 10.2.4.5.2.4 End User
- 10.2.4.6 Rest of Europe Market
- 10.2.4.6.1 Rest of Europe: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.2.4.6.2 Rest of Europe: Infertility Testing Market– By Segmentation
- 10.2.4.6.2.1 Type
- 10.2.4.6.2.2 Test Kits
- 10.2.4.6.2.3 Sample
- 10.2.4.6.2.4 End User
- 10.3 Asia Pacific
- 10.3.1 Asia Pacific Infertility Testing Market Overview
- 10.3.2 Asia Pacific: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.3 Asia Pacific: Infertility Testing Market– By Segmentation
- 10.3.3.1 Type
- 10.3.3.2 Test Kits
- 10.3.3.3 Sample
- 10.3.3.4 End User
- 10.3.4 Asia Pacific: Infertility Testing Market Breakdown by Countries
- 10.3.4.1 China Market
- 10.3.4.1.1 China: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.1.2 China: Infertility Testing Market– By Segmentation
- 10.3.4.1.2.1 Type
- 10.3.4.1.2.2 Test Kits
- 10.3.4.1.2.3 Sample
- 10.3.4.1.2.4 End User
- 10.3.4.2 India Market
- 10.3.4.2.1 India: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.2.2 India: Infertility Testing Market– By Segmentation
- 10.3.4.2.2.1 Type
- 10.3.4.2.2.2 Test Kits
- 10.3.4.2.2.3 Sample
- 10.3.4.2.2.4 End User
- 10.3.4.3 Japan Market
- 10.3.4.3.1 Japan: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.3.2 Japan: Infertility Testing Market– By Segmentation
- 10.3.4.3.2.1 Type
- 10.3.4.3.2.2 Test Kits
- 10.3.4.3.2.3 Sample
- 10.3.4.3.2.4 End User
- 10.3.4.4 Australia Market
- 10.3.4.4.1 Australia: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.4.2 Australia: Infertility Testing Market– By Segmentation
- 10.3.4.4.2.1 Type
- 10.3.4.4.2.2 Test Kits
- 10.3.4.4.2.3 Sample
- 10.3.4.4.2.4 End User
- 10.3.4.5 South Korea Market
- 10.3.4.5.1 South Korea: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.5.2 South Korea: Infertility Testing Market– By Segmentation
- 10.3.4.5.2.1 Type
- 10.3.4.5.2.2 Test Kits
- 10.3.4.5.2.3 Sample
- 10.3.4.5.2.4 End User
- 10.3.4.6 Rest of APAC Market
- 10.3.4.6.1 Rest of APAC: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.3.4.6.2 Rest of APAC: Infertility Testing Market– By Segmentation
- 10.3.4.6.2.1 Type
- 10.3.4.6.2.2 Test Kits
- 10.3.4.6.2.3 Sample
- 10.3.4.6.2.4 End User
- 10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Infertility Testing Market Overview
- 10.4.2 Middle East and Africa: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.4.3 Middle East and Africa: Infertility Testing Market– By Segmentation
- 10.4.3.1 Type
- 10.4.3.2 Test Kits
- 10.4.3.3 Sample
- 10.4.3.4 End User
- 10.4.4 Middle East and Africa: Infertility Testing Market Breakdown by Countries
- 10.4.4.1 South Africa Market
- 10.4.4.1.1 South Africa: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.4.4.1.2 South Africa: Infertility Testing Market– By Segmentation
- 10.4.4.1.2.1 Type
- 10.4.4.1.2.2 Test Kits
- 10.4.4.1.2.3 Sample
- 10.4.4.1.2.4 End User
- 10.4.4.2 Saudi Arabia Market
- 10.4.4.2.1 Saudi Arabia: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.4.4.2.2 Saudi Arabia: Infertility Testing Market– By Segmentation
- 10.4.4.2.2.1 Type
- 10.4.4.2.2.2 Test Kits
- 10.4.4.2.2.3 Sample
- 10.4.4.2.2.4 End User
- 10.4.4.3 United Arab Emirates Market
- 10.4.4.3.1 United Arab Emirates: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.4.4.3.2 United Arab Emirates: Infertility Testing Market– By Segmentation
- 10.4.4.3.2.1 Type
- 10.4.4.3.2.2 Test Kits
- 10.4.4.3.2.3 Sample
- 10.4.4.3.2.4 End User
- 10.4.4.4 Rest of Middle East and Africa Market
- 10.4.4.4.1 Rest of Middle East and Africa: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.4.4.4.2 Rest of Middle East and Africa: Infertility Testing Market– By Segmentation
- 10.4.4.4.2.1 Type
- 10.4.4.4.2.2 Test Kits
- 10.4.4.4.2.3 Sample
- 10.4.4.4.2.4 End User
- 10.5 South and Central America
- 10.5.1 South and Central America Infertility Testing Market Overview
- 10.5.2 South and Central America: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.5.3 South and Central America: Infertility Testing Market– By Segmentation
- 10.5.3.1 Type
- 10.5.3.2 Test Kits
- 10.5.3.3 Sample
- 10.5.3.4 End User
- 10.5.4 South and Central America: Infertility Testing Market Breakdown by Countries
- 10.5.4.1 Brazil Market
- 10.5.4.1.1 Brazil: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.5.4.1.2 Brazil: Infertility Testing Market– By Segmentation
- 10.5.4.1.2.1 Type
- 10.5.4.1.2.2 Test Kits
- 10.5.4.1.2.3 Sample
- 10.5.4.1.2.4 End User
- 10.5.4.2 Argentina Market
- 10.5.4.2.1 Argentina: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.5.4.2.2 Argentina: Infertility Testing Market– By Segmentation
- 10.5.4.2.2.1 Type
- 10.5.4.2.2.2 Test Kits
- 10.5.4.2.2.3 Sample
- 10.5.4.2.2.4 End User
- 10.5.4.3 Rest of South and Central America Market
- 10.5.4.3.1 Rest of South and Central America: Infertility Testing Market Revenue and Forecasts, 2021–2031 (US$ Million)
- 10.5.4.3.2 Rest of South and Central America: Infertility Testing Market– By Segmentation
- 10.5.4.3.2.1 Type
- 10.5.4.3.2.2 Test Kits
- 10.5.4.3.2.3 Sample
- 10.5.4.3.2.4 End User
- 11. Infertility Testing Market Industry Landscape
- 12. Infertility Testing Market – Key Company Profiles
- 12.1 Quest Diagnostics Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Church & Dwight Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Swiss Precision Diagnostics GmbH
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 QuidelOrtho Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 bioMerieux SA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Thermo Fisher Scientific Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Prestige Consumer Healthcare Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 LetsGetChecked
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Mira
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 13. Appendix
- 13.1 Glossary
- 13.2 Research Methodology and Approach
- 13.2.1 Secondary Research
- 13.2.2 Primary Research
- 13.2.3 Market Estimation Approach
- 13.2.3.1 Supply Side Analysis
- 13.2.3.2 Demand Side Analysis
- 13.2.4 Research Assumptions and Limitations
- 13.2.5 Currency Conversion
- 13.3 About The Insight Partners
- 13.4 Market Intelligence Cloud
- Table 1. Infertility Testing Market Segmentation
- Table 2. List of Regulatory Bodies and Organizations
- Table 3. Ease of Doing Business: Key Country Rankings
- Table 4. Infertility Testing Market – Revenue, 2021–2024(US$ Million)
- Table 5. Infertility Testing Market – Revenue Forecast, 2025–2031(US$ Million)
- Table 6. Infertility Testing Market – Revenue, 2021–2024(US$ Million) – by Type
- Table 7. Infertility Testing Market – Revenue Forecast, 2025–2031(US$ Million) – by Type
- Table 8. Infertility Testing Market – Revenue, 2021–2024(US$ Million) – by Test Kits
- Table 9. Infertility Testing Market – Revenue Forecast, 2025–2031(US$ Million) – by Test Kits
- Table 10. Infertility Testing Market – Revenue, 2021–2024(US$ Million) – by Sample
- Table 11. Infertility Testing Market – Revenue Forecast, 2025–2031(US$ Million) – by Sample
- Table 12. Infertility Testing Market – Revenue, 2021–2024(US$ Million) – by End User
- Table 13. Infertility Testing Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
- Table 14. North America: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 15. North America: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 16. North America: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 17. North America: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 18. North America: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 19. North America: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 20. North America: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 21. North America: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 22. North America: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Country
- Table 23. North America: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
- Table 24. United States: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 25. United States: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 26. United States: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 27. United States: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 28. United States: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 29. United States: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 30. United States: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 31. United States: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 32. Canada: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 33. Canada: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 34. Canada: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 35. Canada: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 36. Canada: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 37. Canada: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 38. Canada: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 39. Canada: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 40. Mexico: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 41. Mexico: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 42. Mexico: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 43. Mexico: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 44. Mexico: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 45. Mexico: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 46. Mexico: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 47. Mexico: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 48. Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 49. Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 50. Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 51. Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 52. Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 53. Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 54. Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 55. Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 56. Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Country
- Table 57. Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
- Table 58. United Kingdom: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 59. United Kingdom: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 60. United Kingdom: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 61. United Kingdom: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 62. United Kingdom: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 63. United Kingdom: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 64. United Kingdom: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 65. United Kingdom: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 66. Germany: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 67. Germany: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 68. Germany: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 69. Germany: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 70. Germany: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 71. Germany: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 72. Germany: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 73. Germany: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 74. Italy: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 75. Italy: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 76. Italy: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 77. Italy: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 78. Italy: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 79. Italy: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 80. Italy: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 81. Italy: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 82. France: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 83. France: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 84. France: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 85. France: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 86. France: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 87. France: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 88. France: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 89. France: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 90. Spain: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 91. Spain: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 92. Spain: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 93. Spain: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 94. Spain: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 95. Spain: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 96. Spain: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 97. Spain: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 98. Rest of Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 99. Rest of Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 100. Rest of Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 101. Rest of Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 102. Rest of Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 103. Rest of Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 104. Rest of Europe: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 105. Rest of Europe: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 106. Asia Pacific: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 107. Asia Pacific: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 108. Asia Pacific: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 109. Asia Pacific: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 110. Asia Pacific: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 111. Asia Pacific: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 112. Asia Pacific: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 113. Asia Pacific: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 114. Asia Pacific: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Country
- Table 115. Asia Pacific: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
- Table 116. China: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 117. China: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 118. China: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 119. China: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 120. China: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 121. China: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 122. China: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 123. China: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 124. India: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 125. India: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 126. India: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 127. India: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 128. India: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 129. India: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 130. India: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 131. India: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 132. Japan: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 133. Japan: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 134. Japan: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 135. Japan: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 136. Japan: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 137. Japan: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 138. Japan: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 139. Japan: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 140. Australia: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 141. Australia: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
- Table 142. Australia: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Test Kits
- Table 143. Australia: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Test Kits
- Table 144. Australia: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Sample
- Table 145. Australia: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Sample
- Table 146. Australia: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 147. Australia: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 148. South Korea: Infertility Testing Market – Revenue, 2021–2024 (US$ Million) – by Type
- Table 149. South Korea: Infertility Testing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
